戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                    Patients were randomly assigned in a 1:1 ratio and by permuted block r
2                                                    Patients were randomly assigned in a 1:1 ratio either to the early com
3                                                       Girls were randomly assigned in a 1:1 ratio to 1 of 2 groups within
4           Patients with histologically confirmed primary BC were randomly assigned in a 1:1 ratio to 12 times weekly NAB-
5                                                    Patients were randomly assigned in a 1:1 ratio to adjuvant radiotherap
6                                                  Clinicians were randomly assigned in a 1:1 ratio to an EHR configuration
7  persistent atrial fibrillation in sinus rhythm at baseline were randomly assigned in a 1:1 ratio to either abstain from
8                                                Participants were randomly assigned in a 1:1 ratio to either endometrial s
9           Patients with osteoarthritis in one or both knees were randomly assigned in a 1:1 ratio to receive a glucocorti
10                                                Participants were randomly assigned in a 1:1 ratio to receive active inter
11                                                Participants were randomly assigned in a 1:1 ratio to receive active inter
12 linical response (i.e., met prespecified response criteria) were randomly assigned in a 1:1 ratio to receive continued ri
13                                                    Patients were randomly assigned in a 1:1 ratio to receive either incli
14                    The trial enrolled 30,420 volunteers who were randomly assigned in a 1:1 ratio to receive either vacci
15                                                Participants were randomly assigned in a 1:1 ratio to receive gabapentin (
16                                      A total of 70 patients were randomly assigned in a 1:1 ratio to receive nemolizumab
17                                                Participants were randomly assigned in a 1:1 ratio to receive olanzapine o
18                                                The patients were randomly assigned in a 1:1 ratio to receive once-daily t
19 of body-surface area), and risks for cardiovascular disease were randomly assigned in a 1:1 ratio to receive sotagliflozi
20 e treated within 8 hours after the onset of stroke symptoms were randomly assigned in a 1:1 ratio to receive standard car
21                                                    Patients were randomly assigned in a 1:1 ratio to receive three cycles
22 th an estimated GFR of 25 to 44 ml per minute per 1.73 m(2) were randomly assigned in a 1:1 ratio to receive tolvaptan or
23                                                Participants were randomly assigned in a 1:1 ratio to receive two doses of
24  at high risk for SARS-CoV-2 infection or its complications were randomly assigned in a 1:1 ratio to receive two intramus
25 nts recruited in Ivory Coast, Uganda, Cambodia, and Vietnam were randomly assigned in a 1:1 ratio to undergo screening (X
26 0 to 1), stratified by histology (epithelioid or biphasic), were randomly assigned in a 1:1 ratio to up to six cycles of
27                                                Participants were randomly assigned in a 1:1 ratio to use CGM (n = 103) or
28                        Patients with resistant hypertension were randomly assigned in a 1:1:1 manner to receive either tr
29                                         Eligible candidates were randomly assigned in a 1:1:1 ratio to participate in 1 o
30                                 A total of 274 participants were randomly assigned in a 1:1:1 ratio to receive a once-dai
31                                                    Patients were randomly assigned in a 1:1:1 ratio to receive standard c
32                     All patients received standard care and were randomly assigned in a 1:1:1:1 ratio to intravenous admi
33                                                Participants were randomly assigned in a 1:1:1:1 ratio to receive 0.05%, 0
34 by a 12-week double-blind treatment phase in which patients were randomly assigned in a 1:1:1:1 ratio to receive olanzapi
35       Healthy children and adolescents 4 to 16 years of age were randomly assigned in a 2:1 ratio (stratified according t
36                                                    Patients were randomly assigned in a 2:1 ratio to intravenous remdesiv
37 e to maintain, as determined by the investigator.) Patients were randomly assigned in a 2:1 ratio to receive bempedoic ac
38                                                    Patients were randomly assigned in a 2:1 ratio to receive darolutamide
39      Patients who were taking a stable dose of methotrexate were randomly assigned in a 2:1 ratio to receive either adali
40  level of 400 mg per deciliter (4.5 mmol per liter) or less were randomly assigned in a 2:1 ratio to receive monthly subc
41                                                Participants were randomly assigned in a 2:1 ratio to receive sodium pheny
42                                                    Patients were randomly assigned in a 2:1 ratio to receive standard car
43                                                Participants were randomly assigned in a 2:1 ratio to STEP-KOA or an arthr
44                                        In group 2, patients were randomly assigned in a 3:1 ratio to receive 1200 million
45                                                    Patients were randomly assigned in a 3:1 ratio to receive either activ
46   In each dose cohort (20, 40, 60, or 100 mg), participants were randomly assigned in a 3:1 ratio to receive five doses o
47                                                    Patients were randomly assigned in a 3:1 ratio to receive HTT(Rx) or p
48                                                    Patients were randomly assigned in a 3:2 ratio to oral ixazomib or mat
49 agnetic resonance imaging (MRI)-documented lacunar infarcts were randomly assigned in a factorial design to target levels
50                                                    Patients were randomly assigned in a response-adaptive manner, using B